nodes	percent_of_prediction	percent_of_DWPC	metapath
Trazodone—ABCB1—Lisinopril—dilated cardiomyopathy	0.114	0.532	CbGbCtD
Trazodone—ABCB1—Spironolactone—dilated cardiomyopathy	0.1	0.468	CbGbCtD
Trazodone—HTR2B—cardial valve—dilated cardiomyopathy	0.0522	0.61	CbGeAlD
Trazodone—Menstruation irregular—Spironolactone—dilated cardiomyopathy	0.0183	0.0346	CcSEcCtD
Trazodone—Diuresis—Furosemide—dilated cardiomyopathy	0.0178	0.0336	CcSEcCtD
Trazodone—Incontinence—Furosemide—dilated cardiomyopathy	0.0158	0.0298	CcSEcCtD
Trazodone—Breast enlargement—Spironolactone—dilated cardiomyopathy	0.0156	0.0295	CcSEcCtD
Trazodone—HTR2A—pulmonary artery—dilated cardiomyopathy	0.0113	0.132	CbGeAlD
Trazodone—HTR2A—sympathetic nervous system—dilated cardiomyopathy	0.011	0.128	CbGeAlD
Trazodone—Vasculitis—Spironolactone—dilated cardiomyopathy	0.0104	0.0196	CcSEcCtD
Trazodone—Cerebration impaired—Furosemide—dilated cardiomyopathy	0.00936	0.0177	CcSEcCtD
Trazodone—Trifluoperazine—TNNC1—dilated cardiomyopathy	0.00931	0.687	CrCbGaD
Trazodone—Eruption—Furosemide—dilated cardiomyopathy	0.00895	0.0169	CcSEcCtD
Trazodone—Lethargy—Spironolactone—dilated cardiomyopathy	0.00749	0.0142	CcSEcCtD
Trazodone—Cholestasis—Furosemide—dilated cardiomyopathy	0.00725	0.0137	CcSEcCtD
Trazodone—Inappropriate antidiuretic hormone secretion—Lisinopril—dilated cardiomyopathy	0.00711	0.0134	CcSEcCtD
Trazodone—Ataxia—Spironolactone—dilated cardiomyopathy	0.00691	0.0131	CcSEcCtD
Trazodone—Psoriasis—Lisinopril—dilated cardiomyopathy	0.00657	0.0124	CcSEcCtD
Trazodone—Disturbance in attention—Furosemide—dilated cardiomyopathy	0.00635	0.012	CcSEcCtD
Trazodone—Jaundice cholestatic—Furosemide—dilated cardiomyopathy	0.00626	0.0118	CcSEcCtD
Trazodone—Erectile dysfunction—Spironolactone—dilated cardiomyopathy	0.00585	0.0111	CcSEcCtD
Trazodone—Hearing impaired—Furosemide—dilated cardiomyopathy	0.00578	0.0109	CcSEcCtD
Trazodone—Drowsiness—Spironolactone—dilated cardiomyopathy	0.00566	0.0107	CcSEcCtD
Trazodone—Vasculitis—Furosemide—dilated cardiomyopathy	0.00564	0.0107	CcSEcCtD
Trazodone—Memory impairment—Lisinopril—dilated cardiomyopathy	0.00526	0.00995	CcSEcCtD
Trazodone—Bladder pain—Furosemide—dilated cardiomyopathy	0.00498	0.00941	CcSEcCtD
Trazodone—Lightheadedness—Furosemide—dilated cardiomyopathy	0.00492	0.00931	CcSEcCtD
Trazodone—Mental disability—Furosemide—dilated cardiomyopathy	0.00478	0.00903	CcSEcCtD
Trazodone—Jaundice cholestatic—Lisinopril—dilated cardiomyopathy	0.0047	0.00889	CcSEcCtD
Trazodone—Ventricular extrasystoles—Lisinopril—dilated cardiomyopathy	0.00457	0.00865	CcSEcCtD
Trazodone—Photosensitivity—Furosemide—dilated cardiomyopathy	0.00455	0.00861	CcSEcCtD
Trazodone—Polyuria—Furosemide—dilated cardiomyopathy	0.00455	0.00861	CcSEcCtD
Trazodone—Alopecia—Spironolactone—dilated cardiomyopathy	0.00449	0.00849	CcSEcCtD
Trazodone—Deafness—Furosemide—dilated cardiomyopathy	0.00447	0.00845	CcSEcCtD
Trazodone—Haemolytic anaemia—Furosemide—dilated cardiomyopathy	0.00443	0.00837	CcSEcCtD
Trazodone—Leukocytosis—Lisinopril—dilated cardiomyopathy	0.00439	0.00831	CcSEcCtD
Trazodone—Vasculitis—Lisinopril—dilated cardiomyopathy	0.00423	0.008	CcSEcCtD
Trazodone—Ventricular tachycardia—Lisinopril—dilated cardiomyopathy	0.00413	0.00781	CcSEcCtD
Trazodone—Ill-defined disorder—Spironolactone—dilated cardiomyopathy	0.0041	0.00776	CcSEcCtD
Trazodone—Lethargy—Furosemide—dilated cardiomyopathy	0.00408	0.00771	CcSEcCtD
Trazodone—Hyponatraemia—Furosemide—dilated cardiomyopathy	0.00401	0.00759	CcSEcCtD
Trazodone—Salivary hypersecretion—Lisinopril—dilated cardiomyopathy	0.00401	0.00758	CcSEcCtD
Trazodone—Malaise—Spironolactone—dilated cardiomyopathy	0.00399	0.00754	CcSEcCtD
Trazodone—Photophobia—Lisinopril—dilated cardiomyopathy	0.00388	0.00733	CcSEcCtD
Trazodone—Urinary retention—Furosemide—dilated cardiomyopathy	0.0038	0.00718	CcSEcCtD
Trazodone—Bladder pain—Lisinopril—dilated cardiomyopathy	0.00373	0.00706	CcSEcCtD
Trazodone—Discomfort—Spironolactone—dilated cardiomyopathy	0.00372	0.00704	CcSEcCtD
Trazodone—Lightheadedness—Lisinopril—dilated cardiomyopathy	0.00369	0.00699	CcSEcCtD
Trazodone—Orthostatic hypotension—Furosemide—dilated cardiomyopathy	0.00365	0.0069	CcSEcCtD
Trazodone—Confusional state—Spironolactone—dilated cardiomyopathy	0.00364	0.00688	CcSEcCtD
Trazodone—Photosensitivity—Lisinopril—dilated cardiomyopathy	0.00341	0.00646	CcSEcCtD
Trazodone—Haemolytic anaemia—Lisinopril—dilated cardiomyopathy	0.00332	0.00628	CcSEcCtD
Trazodone—Nasal congestion—Lisinopril—dilated cardiomyopathy	0.00329	0.00622	CcSEcCtD
Trazodone—Libido decreased—Lisinopril—dilated cardiomyopathy	0.00323	0.00611	CcSEcCtD
Trazodone—Somnolence—Spironolactone—dilated cardiomyopathy	0.00321	0.00607	CcSEcCtD
Trazodone—Pollakiuria—Furosemide—dilated cardiomyopathy	0.00319	0.00603	CcSEcCtD
Trazodone—Atrial fibrillation—Lisinopril—dilated cardiomyopathy	0.00316	0.00598	CcSEcCtD
Trazodone—Photosensitivity reaction—Furosemide—dilated cardiomyopathy	0.00315	0.00596	CcSEcCtD
Trazodone—Drowsiness—Furosemide—dilated cardiomyopathy	0.00308	0.00582	CcSEcCtD
Trazodone—Cerebrovascular accident—Lisinopril—dilated cardiomyopathy	0.00306	0.00579	CcSEcCtD
Trazodone—Hyponatraemia—Lisinopril—dilated cardiomyopathy	0.00301	0.00569	CcSEcCtD
Trazodone—Diplopia—Lisinopril—dilated cardiomyopathy	0.003	0.00567	CcSEcCtD
Trazodone—Feeling abnormal—Spironolactone—dilated cardiomyopathy	0.00297	0.00563	CcSEcCtD
Trazodone—Disturbance in sexual arousal—Lisinopril—dilated cardiomyopathy	0.00297	0.00562	CcSEcCtD
Trazodone—Sweating—Furosemide—dilated cardiomyopathy	0.00295	0.00558	CcSEcCtD
Trazodone—HTR2B—heart—dilated cardiomyopathy	0.00288	0.0337	CbGeAlD
Trazodone—Urticaria—Spironolactone—dilated cardiomyopathy	0.00287	0.00542	CcSEcCtD
Trazodone—Body temperature increased—Spironolactone—dilated cardiomyopathy	0.00285	0.0054	CcSEcCtD
Trazodone—Cardiac arrest—Lisinopril—dilated cardiomyopathy	0.00285	0.00539	CcSEcCtD
Trazodone—Ataxia—Lisinopril—dilated cardiomyopathy	0.00282	0.00533	CcSEcCtD
Trazodone—Orthostatic hypotension—Lisinopril—dilated cardiomyopathy	0.00274	0.00518	CcSEcCtD
Trazodone—Visual impairment—Furosemide—dilated cardiomyopathy	0.00266	0.00504	CcSEcCtD
Trazodone—Hypersensitivity—Spironolactone—dilated cardiomyopathy	0.00266	0.00503	CcSEcCtD
Trazodone—Aripiprazole—ADRB1—dilated cardiomyopathy	0.00258	0.191	CrCbGaD
Trazodone—Tinnitus—Furosemide—dilated cardiomyopathy	0.00258	0.00487	CcSEcCtD
Trazodone—Pruritus—Spironolactone—dilated cardiomyopathy	0.00255	0.00483	CcSEcCtD
Trazodone—Diarrhoea—Spironolactone—dilated cardiomyopathy	0.00247	0.00467	CcSEcCtD
Trazodone—Arrhythmia—Furosemide—dilated cardiomyopathy	0.00247	0.00467	CcSEcCtD
Trazodone—Dizziness—Spironolactone—dilated cardiomyopathy	0.00239	0.00451	CcSEcCtD
Trazodone—Erectile dysfunction—Lisinopril—dilated cardiomyopathy	0.00239	0.00451	CcSEcCtD
Trazodone—ADRA1A—heart—dilated cardiomyopathy	0.00238	0.0278	CbGeAlD
Trazodone—Flatulence—Furosemide—dilated cardiomyopathy	0.00237	0.00448	CcSEcCtD
Trazodone—Photosensitivity reaction—Lisinopril—dilated cardiomyopathy	0.00236	0.00447	CcSEcCtD
Trazodone—Weight increased—Lisinopril—dilated cardiomyopathy	0.00236	0.00446	CcSEcCtD
Trazodone—Dysgeusia—Furosemide—dilated cardiomyopathy	0.00236	0.00446	CcSEcCtD
Trazodone—Weight decreased—Lisinopril—dilated cardiomyopathy	0.00234	0.00443	CcSEcCtD
Trazodone—Vomiting—Spironolactone—dilated cardiomyopathy	0.00229	0.00434	CcSEcCtD
Trazodone—Acute coronary syndrome—Lisinopril—dilated cardiomyopathy	0.00228	0.00431	CcSEcCtD
Trazodone—Rash—Spironolactone—dilated cardiomyopathy	0.00228	0.0043	CcSEcCtD
Trazodone—Dermatitis—Spironolactone—dilated cardiomyopathy	0.00227	0.0043	CcSEcCtD
Trazodone—Vision blurred—Furosemide—dilated cardiomyopathy	0.00227	0.00429	CcSEcCtD
Trazodone—Myocardial infarction—Lisinopril—dilated cardiomyopathy	0.00226	0.00428	CcSEcCtD
Trazodone—Headache—Spironolactone—dilated cardiomyopathy	0.00226	0.00428	CcSEcCtD
Trazodone—Jaundice—Lisinopril—dilated cardiomyopathy	0.00225	0.00426	CcSEcCtD
Trazodone—Anaemia—Furosemide—dilated cardiomyopathy	0.00222	0.00421	CcSEcCtD
Trazodone—Sweating—Lisinopril—dilated cardiomyopathy	0.00221	0.00419	CcSEcCtD
Trazodone—Agitation—Furosemide—dilated cardiomyopathy	0.00221	0.00418	CcSEcCtD
Trazodone—Haematuria—Lisinopril—dilated cardiomyopathy	0.0022	0.00417	CcSEcCtD
Trazodone—Vertigo—Furosemide—dilated cardiomyopathy	0.00216	0.00409	CcSEcCtD
Trazodone—Nausea—Spironolactone—dilated cardiomyopathy	0.00214	0.00405	CcSEcCtD
Trazodone—Bradycardia—Lisinopril—dilated cardiomyopathy	0.00211	0.00399	CcSEcCtD
Trazodone—Hallucination—Lisinopril—dilated cardiomyopathy	0.00206	0.0039	CcSEcCtD
Trazodone—Dry mouth—Furosemide—dilated cardiomyopathy	0.002	0.00379	CcSEcCtD
Trazodone—Confusional state—Furosemide—dilated cardiomyopathy	0.00198	0.00374	CcSEcCtD
Trazodone—Tinnitus—Lisinopril—dilated cardiomyopathy	0.00193	0.00366	CcSEcCtD
Trazodone—Shock—Furosemide—dilated cardiomyopathy	0.00193	0.00365	CcSEcCtD
Trazodone—Flushing—Lisinopril—dilated cardiomyopathy	0.00192	0.00364	CcSEcCtD
Trazodone—Hyperhidrosis—Furosemide—dilated cardiomyopathy	0.0019	0.00359	CcSEcCtD
Trazodone—Anorexia—Furosemide—dilated cardiomyopathy	0.00187	0.00354	CcSEcCtD
Trazodone—Chills—Lisinopril—dilated cardiomyopathy	0.00186	0.00352	CcSEcCtD
Trazodone—Arrhythmia—Lisinopril—dilated cardiomyopathy	0.00185	0.0035	CcSEcCtD
Trazodone—Hypotension—Furosemide—dilated cardiomyopathy	0.00183	0.00347	CcSEcCtD
Trazodone—Alopecia—Lisinopril—dilated cardiomyopathy	0.00183	0.00347	CcSEcCtD
Trazodone—ADRA2A—heart—dilated cardiomyopathy	0.00181	0.0212	CbGeAlD
Trazodone—Flatulence—Lisinopril—dilated cardiomyopathy	0.00178	0.00336	CcSEcCtD
Trazodone—Tension—Lisinopril—dilated cardiomyopathy	0.00177	0.00335	CcSEcCtD
Trazodone—Dysgeusia—Lisinopril—dilated cardiomyopathy	0.00177	0.00334	CcSEcCtD
Trazodone—Paraesthesia—Furosemide—dilated cardiomyopathy	0.00176	0.00333	CcSEcCtD
Trazodone—Nervousness—Lisinopril—dilated cardiomyopathy	0.00175	0.00332	CcSEcCtD
Trazodone—Back pain—Lisinopril—dilated cardiomyopathy	0.00175	0.0033	CcSEcCtD
Trazodone—Somnolence—Furosemide—dilated cardiomyopathy	0.00175	0.0033	CcSEcCtD
Trazodone—Decreased appetite—Furosemide—dilated cardiomyopathy	0.00171	0.00323	CcSEcCtD
Trazodone—Vision blurred—Lisinopril—dilated cardiomyopathy	0.0017	0.00322	CcSEcCtD
Trazodone—Fatigue—Furosemide—dilated cardiomyopathy	0.00169	0.0032	CcSEcCtD
Trazodone—Tremor—Lisinopril—dilated cardiomyopathy	0.00169	0.0032	CcSEcCtD
Trazodone—Constipation—Furosemide—dilated cardiomyopathy	0.00168	0.00318	CcSEcCtD
Trazodone—Pain—Furosemide—dilated cardiomyopathy	0.00168	0.00318	CcSEcCtD
Trazodone—Ill-defined disorder—Lisinopril—dilated cardiomyopathy	0.00168	0.00317	CcSEcCtD
Trazodone—Anaemia—Lisinopril—dilated cardiomyopathy	0.00167	0.00316	CcSEcCtD
Trazodone—Loxapine—ADRB1—dilated cardiomyopathy	0.00165	0.122	CrCbGaD
Trazodone—Malaise—Lisinopril—dilated cardiomyopathy	0.00163	0.00308	CcSEcCtD
Trazodone—Vertigo—Lisinopril—dilated cardiomyopathy	0.00162	0.00307	CcSEcCtD
Trazodone—Syncope—Lisinopril—dilated cardiomyopathy	0.00162	0.00306	CcSEcCtD
Trazodone—Feeling abnormal—Furosemide—dilated cardiomyopathy	0.00162	0.00306	CcSEcCtD
Trazodone—Gastrointestinal pain—Furosemide—dilated cardiomyopathy	0.00161	0.00304	CcSEcCtD
Trazodone—Palpitations—Lisinopril—dilated cardiomyopathy	0.0016	0.00302	CcSEcCtD
Trazodone—Loss of consciousness—Lisinopril—dilated cardiomyopathy	0.00159	0.003	CcSEcCtD
Trazodone—Urticaria—Furosemide—dilated cardiomyopathy	0.00156	0.00295	CcSEcCtD
Trazodone—Body temperature increased—Furosemide—dilated cardiomyopathy	0.00155	0.00294	CcSEcCtD
Trazodone—Abdominal pain—Furosemide—dilated cardiomyopathy	0.00155	0.00294	CcSEcCtD
Trazodone—ADRA2A—cardiac atrium—dilated cardiomyopathy	0.00155	0.0181	CbGeAlD
Trazodone—HTR2A—heart—dilated cardiomyopathy	0.00154	0.018	CbGeAlD
Trazodone—Chest pain—Lisinopril—dilated cardiomyopathy	0.00154	0.00291	CcSEcCtD
Trazodone—Arthralgia—Lisinopril—dilated cardiomyopathy	0.00154	0.00291	CcSEcCtD
Trazodone—Myalgia—Lisinopril—dilated cardiomyopathy	0.00154	0.00291	CcSEcCtD
Trazodone—Anxiety—Lisinopril—dilated cardiomyopathy	0.00153	0.0029	CcSEcCtD
Trazodone—Discomfort—Lisinopril—dilated cardiomyopathy	0.00152	0.00287	CcSEcCtD
Trazodone—Dry mouth—Lisinopril—dilated cardiomyopathy	0.0015	0.00284	CcSEcCtD
Trazodone—Confusional state—Lisinopril—dilated cardiomyopathy	0.00149	0.00281	CcSEcCtD
Trazodone—Oedema—Lisinopril—dilated cardiomyopathy	0.00147	0.00279	CcSEcCtD
Trazodone—Shock—Lisinopril—dilated cardiomyopathy	0.00145	0.00274	CcSEcCtD
Trazodone—Hypersensitivity—Furosemide—dilated cardiomyopathy	0.00145	0.00274	CcSEcCtD
Trazodone—Tachycardia—Lisinopril—dilated cardiomyopathy	0.00144	0.00272	CcSEcCtD
Trazodone—Hyperhidrosis—Lisinopril—dilated cardiomyopathy	0.00142	0.00269	CcSEcCtD
Trazodone—Asthenia—Furosemide—dilated cardiomyopathy	0.00141	0.00266	CcSEcCtD
Trazodone—Anorexia—Lisinopril—dilated cardiomyopathy	0.0014	0.00266	CcSEcCtD
Trazodone—Pruritus—Furosemide—dilated cardiomyopathy	0.00139	0.00263	CcSEcCtD
Trazodone—Hypotension—Lisinopril—dilated cardiomyopathy	0.00138	0.0026	CcSEcCtD
Trazodone—Diarrhoea—Furosemide—dilated cardiomyopathy	0.00134	0.00254	CcSEcCtD
Trazodone—Musculoskeletal discomfort—Lisinopril—dilated cardiomyopathy	0.00134	0.00254	CcSEcCtD
Trazodone—Insomnia—Lisinopril—dilated cardiomyopathy	0.00133	0.00252	CcSEcCtD
Trazodone—Paraesthesia—Lisinopril—dilated cardiomyopathy	0.00132	0.0025	CcSEcCtD
Trazodone—Dyspnoea—Lisinopril—dilated cardiomyopathy	0.00131	0.00248	CcSEcCtD
Trazodone—Somnolence—Lisinopril—dilated cardiomyopathy	0.00131	0.00248	CcSEcCtD
Trazodone—Dizziness—Furosemide—dilated cardiomyopathy	0.0013	0.00246	CcSEcCtD
Trazodone—Decreased appetite—Lisinopril—dilated cardiomyopathy	0.00128	0.00242	CcSEcCtD
Trazodone—Fatigue—Lisinopril—dilated cardiomyopathy	0.00127	0.0024	CcSEcCtD
Trazodone—Pain—Lisinopril—dilated cardiomyopathy	0.00126	0.00238	CcSEcCtD
Trazodone—Constipation—Lisinopril—dilated cardiomyopathy	0.00126	0.00238	CcSEcCtD
Trazodone—Vomiting—Furosemide—dilated cardiomyopathy	0.00125	0.00236	CcSEcCtD
Trazodone—Rash—Furosemide—dilated cardiomyopathy	0.00124	0.00234	CcSEcCtD
Trazodone—Dermatitis—Furosemide—dilated cardiomyopathy	0.00124	0.00234	CcSEcCtD
Trazodone—Headache—Furosemide—dilated cardiomyopathy	0.00123	0.00233	CcSEcCtD
Trazodone—Feeling abnormal—Lisinopril—dilated cardiomyopathy	0.00121	0.0023	CcSEcCtD
Trazodone—Gastrointestinal pain—Lisinopril—dilated cardiomyopathy	0.0012	0.00228	CcSEcCtD
Trazodone—Urticaria—Lisinopril—dilated cardiomyopathy	0.00117	0.00221	CcSEcCtD
Trazodone—Nausea—Furosemide—dilated cardiomyopathy	0.00117	0.00221	CcSEcCtD
Trazodone—Body temperature increased—Lisinopril—dilated cardiomyopathy	0.00116	0.0022	CcSEcCtD
Trazodone—Abdominal pain—Lisinopril—dilated cardiomyopathy	0.00116	0.0022	CcSEcCtD
Trazodone—Hypersensitivity—Lisinopril—dilated cardiomyopathy	0.00109	0.00205	CcSEcCtD
Trazodone—Asthenia—Lisinopril—dilated cardiomyopathy	0.00106	0.002	CcSEcCtD
Trazodone—Pruritus—Lisinopril—dilated cardiomyopathy	0.00104	0.00197	CcSEcCtD
Trazodone—ABCB1—heart—dilated cardiomyopathy	0.00101	0.0118	CbGeAlD
Trazodone—Diarrhoea—Lisinopril—dilated cardiomyopathy	0.00101	0.00191	CcSEcCtD
Trazodone—Dizziness—Lisinopril—dilated cardiomyopathy	0.000974	0.00184	CcSEcCtD
Trazodone—Vomiting—Lisinopril—dilated cardiomyopathy	0.000937	0.00177	CcSEcCtD
Trazodone—Rash—Lisinopril—dilated cardiomyopathy	0.000929	0.00176	CcSEcCtD
Trazodone—Dermatitis—Lisinopril—dilated cardiomyopathy	0.000928	0.00176	CcSEcCtD
Trazodone—Headache—Lisinopril—dilated cardiomyopathy	0.000923	0.00175	CcSEcCtD
Trazodone—Nausea—Lisinopril—dilated cardiomyopathy	0.000875	0.00166	CcSEcCtD
Trazodone—HTR2C—GPCR downstream signaling—AGTR2—dilated cardiomyopathy	0.000138	0.000872	CbGpPWpGaD
Trazodone—HTR2C—GPCR downstream signaling—CXCL2—dilated cardiomyopathy	0.000138	0.000872	CbGpPWpGaD
Trazodone—HTR1A—SIDS Susceptibility Pathways—TNF—dilated cardiomyopathy	0.000138	0.000872	CbGpPWpGaD
Trazodone—ADRA2A—Class A/1 (Rhodopsin-like receptors)—AGT—dilated cardiomyopathy	0.000137	0.000866	CbGpPWpGaD
Trazodone—HTR1A—GPCR ligand binding—AGT—dilated cardiomyopathy	0.000133	0.00084	CbGpPWpGaD
Trazodone—HTR2C—GPCR ligand binding—AGT—dilated cardiomyopathy	0.000132	0.000835	CbGpPWpGaD
Trazodone—HTR2B—GPCR downstream signaling—AGTR1—dilated cardiomyopathy	0.000132	0.000831	CbGpPWpGaD
Trazodone—ABCB1—Allograft Rejection—TNF—dilated cardiomyopathy	0.000129	0.000817	CbGpPWpGaD
Trazodone—ABCB1—Metabolism—ANKRD1—dilated cardiomyopathy	0.000129	0.000817	CbGpPWpGaD
Trazodone—HTR1A—GPCR downstream signaling—CXCR3—dilated cardiomyopathy	0.000129	0.000815	CbGpPWpGaD
Trazodone—HTR2C—GPCR downstream signaling—CXCR3—dilated cardiomyopathy	0.000129	0.000811	CbGpPWpGaD
Trazodone—HTR1A—Signaling by GPCR—CXCL2—dilated cardiomyopathy	0.000126	0.000796	CbGpPWpGaD
Trazodone—HTR1A—Signaling by GPCR—AGTR2—dilated cardiomyopathy	0.000126	0.000796	CbGpPWpGaD
Trazodone—ADRA2A—Platelet activation, signaling and aggregation—RAF1—dilated cardiomyopathy	0.000126	0.000794	CbGpPWpGaD
Trazodone—HTR2C—Signaling by GPCR—CXCL2—dilated cardiomyopathy	0.000126	0.000792	CbGpPWpGaD
Trazodone—HTR2C—Signaling by GPCR—AGTR2—dilated cardiomyopathy	0.000126	0.000792	CbGpPWpGaD
Trazodone—HTR1A—GPCR downstream signaling—ADRB1—dilated cardiomyopathy	0.000125	0.000789	CbGpPWpGaD
Trazodone—HTR2B—GPCR downstream signaling—ADRB2—dilated cardiomyopathy	0.000125	0.000789	CbGpPWpGaD
Trazodone—HTR2C—GPCR downstream signaling—ADRB1—dilated cardiomyopathy	0.000124	0.000785	CbGpPWpGaD
Trazodone—CYP2D6—Metabolism—ANKRD1—dilated cardiomyopathy	0.000122	0.00077	CbGpPWpGaD
Trazodone—ADRA2A—Hemostasis—ITGB1—dilated cardiomyopathy	0.000122	0.000768	CbGpPWpGaD
Trazodone—ABCB1—Metabolism—TAZ—dilated cardiomyopathy	0.000122	0.000768	CbGpPWpGaD
Trazodone—HTR2A—GPCR downstream signaling—CXCL2—dilated cardiomyopathy	0.00012	0.000757	CbGpPWpGaD
Trazodone—HTR2A—GPCR downstream signaling—AGTR2—dilated cardiomyopathy	0.00012	0.000757	CbGpPWpGaD
Trazodone—HRH1—GPCR downstream signaling—CXCL2—dilated cardiomyopathy	0.00012	0.000756	CbGpPWpGaD
Trazodone—HRH1—GPCR downstream signaling—AGTR2—dilated cardiomyopathy	0.00012	0.000756	CbGpPWpGaD
Trazodone—HTR2B—Signaling by GPCR—AGTR1—dilated cardiomyopathy	0.00012	0.000755	CbGpPWpGaD
Trazodone—HTR2A—SIDS Susceptibility Pathways—TNF—dilated cardiomyopathy	0.000119	0.000753	CbGpPWpGaD
Trazodone—ADRA1A—GPCR downstream signaling—CXCL2—dilated cardiomyopathy	0.000118	0.000742	CbGpPWpGaD
Trazodone—ADRA1A—GPCR downstream signaling—AGTR2—dilated cardiomyopathy	0.000118	0.000742	CbGpPWpGaD
Trazodone—HTR1A—Signaling by GPCR—CXCR3—dilated cardiomyopathy	0.000117	0.00074	CbGpPWpGaD
Trazodone—HTR2C—Signaling by GPCR—CXCR3—dilated cardiomyopathy	0.000117	0.000736	CbGpPWpGaD
Trazodone—HTR2A—GPCR ligand binding—AGT—dilated cardiomyopathy	0.000115	0.000725	CbGpPWpGaD
Trazodone—HRH1—GPCR ligand binding—AGT—dilated cardiomyopathy	0.000115	0.000724	CbGpPWpGaD
Trazodone—CYP2D6—Metabolism—TAZ—dilated cardiomyopathy	0.000115	0.000724	CbGpPWpGaD
Trazodone—HTR1A—Signaling by GPCR—ADRB1—dilated cardiomyopathy	0.000114	0.000717	CbGpPWpGaD
Trazodone—HTR2B—Signaling by GPCR—ADRB2—dilated cardiomyopathy	0.000114	0.000716	CbGpPWpGaD
Trazodone—HTR2C—Signaling by GPCR—ADRB1—dilated cardiomyopathy	0.000113	0.000713	CbGpPWpGaD
Trazodone—ADRA1A—GPCR ligand binding—AGT—dilated cardiomyopathy	0.000113	0.00071	CbGpPWpGaD
Trazodone—HTR2C—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—dilated cardiomyopathy	0.000112	0.000705	CbGpPWpGaD
Trazodone—HTR2A—GPCR downstream signaling—CXCR3—dilated cardiomyopathy	0.000112	0.000704	CbGpPWpGaD
Trazodone—HRH1—GPCR downstream signaling—CXCR3—dilated cardiomyopathy	0.000111	0.000703	CbGpPWpGaD
Trazodone—ABCB1—Metabolism—SDHA—dilated cardiomyopathy	0.00011	0.000694	CbGpPWpGaD
Trazodone—ADRA1A—GPCR downstream signaling—CXCR3—dilated cardiomyopathy	0.000109	0.000689	CbGpPWpGaD
Trazodone—ADRA2A—GPCR downstream signaling—CXCL2—dilated cardiomyopathy	0.000109	0.000689	CbGpPWpGaD
Trazodone—ADRA2A—GPCR downstream signaling—AGTR2—dilated cardiomyopathy	0.000109	0.000689	CbGpPWpGaD
Trazodone—HTR2A—Signaling by GPCR—CXCL2—dilated cardiomyopathy	0.000109	0.000688	CbGpPWpGaD
Trazodone—HTR2A—Signaling by GPCR—AGTR2—dilated cardiomyopathy	0.000109	0.000688	CbGpPWpGaD
Trazodone—HRH1—Signaling by GPCR—CXCL2—dilated cardiomyopathy	0.000109	0.000686	CbGpPWpGaD
Trazodone—HRH1—Signaling by GPCR—AGTR2—dilated cardiomyopathy	0.000109	0.000686	CbGpPWpGaD
Trazodone—HTR2A—GPCR downstream signaling—ADRB1—dilated cardiomyopathy	0.000108	0.000682	CbGpPWpGaD
Trazodone—HRH1—GPCR downstream signaling—ADRB1—dilated cardiomyopathy	0.000108	0.000681	CbGpPWpGaD
Trazodone—HTR1A—GPCR downstream signaling—AGTR1—dilated cardiomyopathy	0.000107	0.000674	CbGpPWpGaD
Trazodone—ADRA1A—Signaling by GPCR—CXCL2—dilated cardiomyopathy	0.000107	0.000673	CbGpPWpGaD
Trazodone—ADRA1A—Signaling by GPCR—AGTR2—dilated cardiomyopathy	0.000107	0.000673	CbGpPWpGaD
Trazodone—HTR2C—GPCR downstream signaling—AGTR1—dilated cardiomyopathy	0.000106	0.000671	CbGpPWpGaD
Trazodone—ADRA1A—GPCR downstream signaling—ADRB1—dilated cardiomyopathy	0.000106	0.000668	CbGpPWpGaD
Trazodone—ADRA2A—GPCR ligand binding—AGT—dilated cardiomyopathy	0.000105	0.00066	CbGpPWpGaD
Trazodone—ADRA2A—Hemostasis—CD36—dilated cardiomyopathy	0.000104	0.000655	CbGpPWpGaD
Trazodone—CYP2D6—Metabolism—SDHA—dilated cardiomyopathy	0.000104	0.000654	CbGpPWpGaD
Trazodone—HTR2B—Signaling Pathways—PSEN2—dilated cardiomyopathy	0.000104	0.000653	CbGpPWpGaD
Trazodone—ADRA2A—GPCR downstream signaling—CXCR3—dilated cardiomyopathy	0.000102	0.000641	CbGpPWpGaD
Trazodone—HTR1A—GPCR downstream signaling—ADRB2—dilated cardiomyopathy	0.000101	0.00064	CbGpPWpGaD
Trazodone—HTR2A—Signaling by GPCR—CXCR3—dilated cardiomyopathy	0.000101	0.000639	CbGpPWpGaD
Trazodone—HRH1—Signaling by GPCR—CXCR3—dilated cardiomyopathy	0.000101	0.000638	CbGpPWpGaD
Trazodone—HTR2C—GPCR downstream signaling—ADRB2—dilated cardiomyopathy	0.000101	0.000636	CbGpPWpGaD
Trazodone—ADRA1A—Signaling by GPCR—CXCR3—dilated cardiomyopathy	9.92e-05	0.000626	CbGpPWpGaD
Trazodone—ADRA2A—Signaling by GPCR—CXCL2—dilated cardiomyopathy	9.92e-05	0.000626	CbGpPWpGaD
Trazodone—ADRA2A—Signaling by GPCR—AGTR2—dilated cardiomyopathy	9.92e-05	0.000626	CbGpPWpGaD
Trazodone—ADRA2A—GPCR downstream signaling—ADRB1—dilated cardiomyopathy	9.83e-05	0.00062	CbGpPWpGaD
Trazodone—HTR2A—Signaling by GPCR—ADRB1—dilated cardiomyopathy	9.81e-05	0.000619	CbGpPWpGaD
Trazodone—HRH1—Signaling by GPCR—ADRB1—dilated cardiomyopathy	9.79e-05	0.000618	CbGpPWpGaD
Trazodone—ADRA2A—Hemostasis—RAC1—dilated cardiomyopathy	9.79e-05	0.000618	CbGpPWpGaD
Trazodone—ABCB1—Integrated Pancreatic Cancer Pathway—RAF1—dilated cardiomyopathy	9.78e-05	0.000617	CbGpPWpGaD
Trazodone—HTR2B—GPCR downstream signaling—RAC1—dilated cardiomyopathy	9.7e-05	0.000612	CbGpPWpGaD
Trazodone—HTR1A—Signaling by GPCR—AGTR1—dilated cardiomyopathy	9.7e-05	0.000612	CbGpPWpGaD
Trazodone—HTR2A—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—dilated cardiomyopathy	9.7e-05	0.000612	CbGpPWpGaD
Trazodone—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—dilated cardiomyopathy	9.68e-05	0.000611	CbGpPWpGaD
Trazodone—HTR2C—Signaling by GPCR—AGTR1—dilated cardiomyopathy	9.65e-05	0.000609	CbGpPWpGaD
Trazodone—ADRA1A—Signaling by GPCR—ADRB1—dilated cardiomyopathy	9.61e-05	0.000606	CbGpPWpGaD
Trazodone—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—dilated cardiomyopathy	9.5e-05	0.000599	CbGpPWpGaD
Trazodone—HTR2B—GPCR downstream signaling—AGT—dilated cardiomyopathy	9.27e-05	0.000585	CbGpPWpGaD
Trazodone—HTR2A—GPCR downstream signaling—AGTR1—dilated cardiomyopathy	9.23e-05	0.000582	CbGpPWpGaD
Trazodone—ADRA2A—Signaling by GPCR—CXCR3—dilated cardiomyopathy	9.22e-05	0.000582	CbGpPWpGaD
Trazodone—HRH1—GPCR downstream signaling—AGTR1—dilated cardiomyopathy	9.21e-05	0.000581	CbGpPWpGaD
Trazodone—HTR1A—Signaling by GPCR—ADRB2—dilated cardiomyopathy	9.21e-05	0.000581	CbGpPWpGaD
Trazodone—HTR2B—Signaling Pathways—CXCL2—dilated cardiomyopathy	9.19e-05	0.00058	CbGpPWpGaD
Trazodone—HTR2B—Signaling Pathways—AGTR2—dilated cardiomyopathy	9.19e-05	0.00058	CbGpPWpGaD
Trazodone—HTR2C—Signaling by GPCR—ADRB2—dilated cardiomyopathy	9.16e-05	0.000578	CbGpPWpGaD
Trazodone—ADRA1A—GPCR downstream signaling—AGTR1—dilated cardiomyopathy	9.04e-05	0.00057	CbGpPWpGaD
Trazodone—ADRA2A—Signaling by GPCR—ADRB1—dilated cardiomyopathy	8.93e-05	0.000563	CbGpPWpGaD
Trazodone—HTR2B—Signaling by GPCR—RAC1—dilated cardiomyopathy	8.81e-05	0.000556	CbGpPWpGaD
Trazodone—HTR2A—GPCR downstream signaling—ADRB2—dilated cardiomyopathy	8.76e-05	0.000553	CbGpPWpGaD
Trazodone—HRH1—GPCR downstream signaling—ADRB2—dilated cardiomyopathy	8.74e-05	0.000551	CbGpPWpGaD
Trazodone—ADRA1A—GPCR downstream signaling—ADRB2—dilated cardiomyopathy	8.57e-05	0.000541	CbGpPWpGaD
Trazodone—HTR2B—Signaling Pathways—CXCR3—dilated cardiomyopathy	8.55e-05	0.000539	CbGpPWpGaD
Trazodone—HTR2B—Signaling by GPCR—AGT—dilated cardiomyopathy	8.42e-05	0.000531	CbGpPWpGaD
Trazodone—ADRA2A—GPCR downstream signaling—AGTR1—dilated cardiomyopathy	8.4e-05	0.00053	CbGpPWpGaD
Trazodone—HTR1A—Signaling Pathways—PSEN2—dilated cardiomyopathy	8.4e-05	0.00053	CbGpPWpGaD
Trazodone—HTR2A—Signaling by GPCR—AGTR1—dilated cardiomyopathy	8.38e-05	0.000529	CbGpPWpGaD
Trazodone—HRH1—Signaling by GPCR—AGTR1—dilated cardiomyopathy	8.36e-05	0.000528	CbGpPWpGaD
Trazodone—HTR2C—Signaling Pathways—PSEN2—dilated cardiomyopathy	8.35e-05	0.000527	CbGpPWpGaD
Trazodone—HTR2B—Signaling Pathways—ADRB1—dilated cardiomyopathy	8.28e-05	0.000522	CbGpPWpGaD
Trazodone—ADRA1A—Signaling by GPCR—AGTR1—dilated cardiomyopathy	8.21e-05	0.000518	CbGpPWpGaD
Trazodone—CYP3A4—Metabolism—ANKRD1—dilated cardiomyopathy	7.97e-05	0.000503	CbGpPWpGaD
Trazodone—ADRA2A—GPCR downstream signaling—ADRB2—dilated cardiomyopathy	7.97e-05	0.000503	CbGpPWpGaD
Trazodone—HTR2A—Signaling by GPCR—ADRB2—dilated cardiomyopathy	7.95e-05	0.000502	CbGpPWpGaD
Trazodone—HRH1—Signaling by GPCR—ADRB2—dilated cardiomyopathy	7.94e-05	0.000501	CbGpPWpGaD
Trazodone—HTR1A—GPCR downstream signaling—RAC1—dilated cardiomyopathy	7.87e-05	0.000497	CbGpPWpGaD
Trazodone—HTR2C—GPCR downstream signaling—RAC1—dilated cardiomyopathy	7.83e-05	0.000494	CbGpPWpGaD
Trazodone—ADRA1A—Signaling by GPCR—ADRB2—dilated cardiomyopathy	7.79e-05	0.000491	CbGpPWpGaD
Trazodone—ADRA2A—Signaling by GPCR—AGTR1—dilated cardiomyopathy	7.63e-05	0.000481	CbGpPWpGaD
Trazodone—HTR1A—GPCR downstream signaling—AGT—dilated cardiomyopathy	7.52e-05	0.000474	CbGpPWpGaD
Trazodone—CYP3A4—Metabolism—TAZ—dilated cardiomyopathy	7.5e-05	0.000473	CbGpPWpGaD
Trazodone—HTR2C—GPCR downstream signaling—AGT—dilated cardiomyopathy	7.48e-05	0.000472	CbGpPWpGaD
Trazodone—HTR1A—Signaling Pathways—AGTR2—dilated cardiomyopathy	7.45e-05	0.00047	CbGpPWpGaD
Trazodone—HTR1A—Signaling Pathways—CXCL2—dilated cardiomyopathy	7.45e-05	0.00047	CbGpPWpGaD
Trazodone—HTR2C—Signaling Pathways—CXCL2—dilated cardiomyopathy	7.42e-05	0.000468	CbGpPWpGaD
Trazodone—HTR2C—Signaling Pathways—AGTR2—dilated cardiomyopathy	7.42e-05	0.000468	CbGpPWpGaD
Trazodone—HTR2A—Signaling Pathways—PSEN2—dilated cardiomyopathy	7.25e-05	0.000458	CbGpPWpGaD
Trazodone—HRH1—Signaling Pathways—PSEN2—dilated cardiomyopathy	7.24e-05	0.000457	CbGpPWpGaD
Trazodone—ADRA2A—Signaling by GPCR—ADRB2—dilated cardiomyopathy	7.23e-05	0.000457	CbGpPWpGaD
Trazodone—HTR1A—Signaling by GPCR—RAC1—dilated cardiomyopathy	7.15e-05	0.000451	CbGpPWpGaD
Trazodone—HTR2C—Signaling by GPCR—RAC1—dilated cardiomyopathy	7.11e-05	0.000449	CbGpPWpGaD
Trazodone—ADRA1A—Signaling Pathways—PSEN2—dilated cardiomyopathy	7.1e-05	0.000448	CbGpPWpGaD
Trazodone—HTR2B—Signaling Pathways—AGTR1—dilated cardiomyopathy	7.07e-05	0.000446	CbGpPWpGaD
Trazodone—HTR1A—Signaling Pathways—CXCR3—dilated cardiomyopathy	6.93e-05	0.000437	CbGpPWpGaD
Trazodone—HTR2C—Signaling Pathways—CXCR3—dilated cardiomyopathy	6.89e-05	0.000435	CbGpPWpGaD
Trazodone—HTR1A—Signaling by GPCR—AGT—dilated cardiomyopathy	6.83e-05	0.000431	CbGpPWpGaD
Trazodone—HTR2A—GPCR downstream signaling—RAC1—dilated cardiomyopathy	6.8e-05	0.000429	CbGpPWpGaD
Trazodone—HTR2C—Signaling by GPCR—AGT—dilated cardiomyopathy	6.79e-05	0.000429	CbGpPWpGaD
Trazodone—HRH1—GPCR downstream signaling—RAC1—dilated cardiomyopathy	6.78e-05	0.000428	CbGpPWpGaD
Trazodone—CYP3A4—Metabolism—SDHA—dilated cardiomyopathy	6.78e-05	0.000428	CbGpPWpGaD
Trazodone—HTR1A—Signaling Pathways—ADRB1—dilated cardiomyopathy	6.71e-05	0.000423	CbGpPWpGaD
Trazodone—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—dilated cardiomyopathy	6.71e-05	0.000423	CbGpPWpGaD
Trazodone—HTR2B—Signaling Pathways—ADRB2—dilated cardiomyopathy	6.71e-05	0.000423	CbGpPWpGaD
Trazodone—HTR2C—Signaling Pathways—ADRB1—dilated cardiomyopathy	6.68e-05	0.000421	CbGpPWpGaD
Trazodone—ADRA1A—GPCR downstream signaling—RAC1—dilated cardiomyopathy	6.66e-05	0.00042	CbGpPWpGaD
Trazodone—ADRA2A—Signaling Pathways—PSEN2—dilated cardiomyopathy	6.6e-05	0.000416	CbGpPWpGaD
Trazodone—HTR2A—GPCR downstream signaling—AGT—dilated cardiomyopathy	6.5e-05	0.00041	CbGpPWpGaD
Trazodone—ADRA2A—Hemostasis—RAF1—dilated cardiomyopathy	6.49e-05	0.000409	CbGpPWpGaD
Trazodone—HRH1—GPCR downstream signaling—AGT—dilated cardiomyopathy	6.48e-05	0.000409	CbGpPWpGaD
Trazodone—HTR2A—Signaling Pathways—AGTR2—dilated cardiomyopathy	6.44e-05	0.000406	CbGpPWpGaD
Trazodone—HTR2A—Signaling Pathways—CXCL2—dilated cardiomyopathy	6.44e-05	0.000406	CbGpPWpGaD
Trazodone—HRH1—Signaling Pathways—AGTR2—dilated cardiomyopathy	6.43e-05	0.000405	CbGpPWpGaD
Trazodone—HRH1—Signaling Pathways—CXCL2—dilated cardiomyopathy	6.43e-05	0.000405	CbGpPWpGaD
Trazodone—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—dilated cardiomyopathy	6.39e-05	0.000403	CbGpPWpGaD
Trazodone—ADRA1A—GPCR downstream signaling—AGT—dilated cardiomyopathy	6.36e-05	0.000401	CbGpPWpGaD
Trazodone—ADRA1A—Signaling Pathways—AGTR2—dilated cardiomyopathy	6.31e-05	0.000398	CbGpPWpGaD
Trazodone—ADRA1A—Signaling Pathways—CXCL2—dilated cardiomyopathy	6.31e-05	0.000398	CbGpPWpGaD
Trazodone—ADRA2A—GPCR downstream signaling—RAC1—dilated cardiomyopathy	6.19e-05	0.00039	CbGpPWpGaD
Trazodone—HTR2A—Signaling by GPCR—RAC1—dilated cardiomyopathy	6.17e-05	0.00039	CbGpPWpGaD
Trazodone—HRH1—Signaling by GPCR—RAC1—dilated cardiomyopathy	6.16e-05	0.000389	CbGpPWpGaD
Trazodone—ADRA1A—Signaling by GPCR—RAC1—dilated cardiomyopathy	6.05e-05	0.000381	CbGpPWpGaD
Trazodone—HTR2A—Signaling Pathways—CXCR3—dilated cardiomyopathy	5.99e-05	0.000378	CbGpPWpGaD
Trazodone—HRH1—Signaling Pathways—CXCR3—dilated cardiomyopathy	5.97e-05	0.000377	CbGpPWpGaD
Trazodone—ADRA2A—GPCR downstream signaling—AGT—dilated cardiomyopathy	5.91e-05	0.000373	CbGpPWpGaD
Trazodone—HTR2A—Signaling by GPCR—AGT—dilated cardiomyopathy	5.9e-05	0.000372	CbGpPWpGaD
Trazodone—HRH1—Signaling by GPCR—AGT—dilated cardiomyopathy	5.89e-05	0.000371	CbGpPWpGaD
Trazodone—ADRA1A—Signaling Pathways—CXCR3—dilated cardiomyopathy	5.86e-05	0.00037	CbGpPWpGaD
Trazodone—ADRA2A—Signaling Pathways—AGTR2—dilated cardiomyopathy	5.86e-05	0.00037	CbGpPWpGaD
Trazodone—ADRA2A—Signaling Pathways—CXCL2—dilated cardiomyopathy	5.86e-05	0.00037	CbGpPWpGaD
Trazodone—HTR2B—Signaling by GPCR—RAF1—dilated cardiomyopathy	5.84e-05	0.000369	CbGpPWpGaD
Trazodone—HTR2A—Signaling Pathways—ADRB1—dilated cardiomyopathy	5.8e-05	0.000366	CbGpPWpGaD
Trazodone—HRH1—Signaling Pathways—ADRB1—dilated cardiomyopathy	5.79e-05	0.000365	CbGpPWpGaD
Trazodone—ADRA1A—Signaling by GPCR—AGT—dilated cardiomyopathy	5.78e-05	0.000364	CbGpPWpGaD
Trazodone—HTR2B—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	5.76e-05	0.000364	CbGpPWpGaD
Trazodone—HTR1A—Signaling Pathways—AGTR1—dilated cardiomyopathy	5.73e-05	0.000362	CbGpPWpGaD
Trazodone—HTR2C—Signaling Pathways—AGTR1—dilated cardiomyopathy	5.7e-05	0.00036	CbGpPWpGaD
Trazodone—ADRA1A—Signaling Pathways—ADRB1—dilated cardiomyopathy	5.68e-05	0.000358	CbGpPWpGaD
Trazodone—ADRA2A—Signaling by GPCR—RAC1—dilated cardiomyopathy	5.62e-05	0.000354	CbGpPWpGaD
Trazodone—CYP3A7—Metabolism—GPX1—dilated cardiomyopathy	5.48e-05	0.000346	CbGpPWpGaD
Trazodone—ADRA2A—Signaling Pathways—CXCR3—dilated cardiomyopathy	5.45e-05	0.000344	CbGpPWpGaD
Trazodone—HTR1A—Signaling Pathways—ADRB2—dilated cardiomyopathy	5.44e-05	0.000343	CbGpPWpGaD
Trazodone—HTR2C—Signaling Pathways—ADRB2—dilated cardiomyopathy	5.41e-05	0.000341	CbGpPWpGaD
Trazodone—ADRA2A—Signaling by GPCR—AGT—dilated cardiomyopathy	5.37e-05	0.000339	CbGpPWpGaD
Trazodone—CYP3A7—Metabolism—CD36—dilated cardiomyopathy	5.34e-05	0.000337	CbGpPWpGaD
Trazodone—ADRA2A—Signaling Pathways—ADRB1—dilated cardiomyopathy	5.27e-05	0.000333	CbGpPWpGaD
Trazodone—HTR2B—Signaling Pathways—RAC1—dilated cardiomyopathy	5.21e-05	0.000328	CbGpPWpGaD
Trazodone—HTR2B—Signaling Pathways—AGT—dilated cardiomyopathy	4.97e-05	0.000314	CbGpPWpGaD
Trazodone—HTR2A—Signaling Pathways—AGTR1—dilated cardiomyopathy	4.95e-05	0.000312	CbGpPWpGaD
Trazodone—HRH1—Signaling Pathways—AGTR1—dilated cardiomyopathy	4.94e-05	0.000312	CbGpPWpGaD
Trazodone—ADRA1A—Signaling Pathways—AGTR1—dilated cardiomyopathy	4.85e-05	0.000306	CbGpPWpGaD
Trazodone—CYP3A7—Metabolism—AGT—dilated cardiomyopathy	4.81e-05	0.000303	CbGpPWpGaD
Trazodone—HTR1A—Signaling by GPCR—RAF1—dilated cardiomyopathy	4.74e-05	0.000299	CbGpPWpGaD
Trazodone—HTR2C—Signaling by GPCR—RAF1—dilated cardiomyopathy	4.71e-05	0.000297	CbGpPWpGaD
Trazodone—HTR2A—Signaling Pathways—ADRB2—dilated cardiomyopathy	4.7e-05	0.000296	CbGpPWpGaD
Trazodone—HRH1—Signaling Pathways—ADRB2—dilated cardiomyopathy	4.69e-05	0.000296	CbGpPWpGaD
Trazodone—HTR1A—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	4.67e-05	0.000295	CbGpPWpGaD
Trazodone—HTR2C—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	4.65e-05	0.000293	CbGpPWpGaD
Trazodone—ADRA1A—Signaling Pathways—ADRB2—dilated cardiomyopathy	4.6e-05	0.00029	CbGpPWpGaD
Trazodone—ADRA2A—Signaling Pathways—AGTR1—dilated cardiomyopathy	4.51e-05	0.000284	CbGpPWpGaD
Trazodone—ADRA2A—Metabolism—GPX1—dilated cardiomyopathy	4.32e-05	0.000273	CbGpPWpGaD
Trazodone—ADRA2A—Signaling Pathways—ADRB2—dilated cardiomyopathy	4.27e-05	0.00027	CbGpPWpGaD
Trazodone—HTR1A—Signaling Pathways—RAC1—dilated cardiomyopathy	4.22e-05	0.000266	CbGpPWpGaD
Trazodone—ADRA2A—Metabolism—CD36—dilated cardiomyopathy	4.21e-05	0.000266	CbGpPWpGaD
Trazodone—HTR2C—Signaling Pathways—RAC1—dilated cardiomyopathy	4.2e-05	0.000265	CbGpPWpGaD
Trazodone—HTR2A—Signaling by GPCR—RAF1—dilated cardiomyopathy	4.09e-05	0.000258	CbGpPWpGaD
Trazodone—HRH1—Signaling by GPCR—RAF1—dilated cardiomyopathy	4.08e-05	0.000258	CbGpPWpGaD
Trazodone—HTR2A—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	4.04e-05	0.000255	CbGpPWpGaD
Trazodone—HTR1A—Signaling Pathways—AGT—dilated cardiomyopathy	4.03e-05	0.000255	CbGpPWpGaD
Trazodone—HRH1—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	4.03e-05	0.000254	CbGpPWpGaD
Trazodone—HTR2C—Signaling Pathways—AGT—dilated cardiomyopathy	4.01e-05	0.000253	CbGpPWpGaD
Trazodone—ADRA1A—Signaling by GPCR—RAF1—dilated cardiomyopathy	4.01e-05	0.000253	CbGpPWpGaD
Trazodone—HTR2B—Signaling by GPCR—EGFR—dilated cardiomyopathy	4.01e-05	0.000253	CbGpPWpGaD
Trazodone—CYP3A5—Metabolism—GPX1—dilated cardiomyopathy	3.96e-05	0.00025	CbGpPWpGaD
Trazodone—ADRA1A—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	3.95e-05	0.000249	CbGpPWpGaD
Trazodone—ABCB1—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	3.88e-05	0.000245	CbGpPWpGaD
Trazodone—CYP3A5—Metabolism—CD36—dilated cardiomyopathy	3.86e-05	0.000243	CbGpPWpGaD
Trazodone—ADRA2A—Metabolism—AGT—dilated cardiomyopathy	3.79e-05	0.000239	CbGpPWpGaD
Trazodone—ADRA2A—Signaling by GPCR—RAF1—dilated cardiomyopathy	3.72e-05	0.000235	CbGpPWpGaD
Trazodone—ADRA2A—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	3.67e-05	0.000232	CbGpPWpGaD
Trazodone—HTR2A—Signaling Pathways—RAC1—dilated cardiomyopathy	3.65e-05	0.00023	CbGpPWpGaD
Trazodone—HRH1—Signaling Pathways—RAC1—dilated cardiomyopathy	3.64e-05	0.00023	CbGpPWpGaD
Trazodone—ADRA1A—Signaling Pathways—RAC1—dilated cardiomyopathy	3.57e-05	0.000225	CbGpPWpGaD
Trazodone—HTR2A—Signaling Pathways—AGT—dilated cardiomyopathy	3.48e-05	0.00022	CbGpPWpGaD
Trazodone—HRH1—Signaling Pathways—AGT—dilated cardiomyopathy	3.48e-05	0.000219	CbGpPWpGaD
Trazodone—CYP3A5—Metabolism—AGT—dilated cardiomyopathy	3.47e-05	0.000219	CbGpPWpGaD
Trazodone—HTR2B—Signaling Pathways—RAF1—dilated cardiomyopathy	3.45e-05	0.000218	CbGpPWpGaD
Trazodone—ADRA1A—Signaling Pathways—AGT—dilated cardiomyopathy	3.41e-05	0.000215	CbGpPWpGaD
Trazodone—ADRA2A—Signaling Pathways—RAC1—dilated cardiomyopathy	3.32e-05	0.000209	CbGpPWpGaD
Trazodone—HTR1A—Signaling by GPCR—EGFR—dilated cardiomyopathy	3.25e-05	0.000205	CbGpPWpGaD
Trazodone—HTR2C—Signaling by GPCR—EGFR—dilated cardiomyopathy	3.23e-05	0.000204	CbGpPWpGaD
Trazodone—ADRA2A—Signaling Pathways—AGT—dilated cardiomyopathy	3.17e-05	0.0002	CbGpPWpGaD
Trazodone—ABCB1—Metabolism—GPX1—dilated cardiomyopathy	2.99e-05	0.000189	CbGpPWpGaD
Trazodone—ABCB1—Metabolism—CD36—dilated cardiomyopathy	2.91e-05	0.000184	CbGpPWpGaD
Trazodone—CYP2D6—Metabolism—GPX1—dilated cardiomyopathy	2.82e-05	0.000178	CbGpPWpGaD
Trazodone—HTR2A—Signaling by GPCR—EGFR—dilated cardiomyopathy	2.81e-05	0.000177	CbGpPWpGaD
Trazodone—HRH1—Signaling by GPCR—EGFR—dilated cardiomyopathy	2.8e-05	0.000177	CbGpPWpGaD
Trazodone—HTR1A—Signaling Pathways—RAF1—dilated cardiomyopathy	2.8e-05	0.000177	CbGpPWpGaD
Trazodone—HTR2C—Signaling Pathways—RAF1—dilated cardiomyopathy	2.78e-05	0.000176	CbGpPWpGaD
Trazodone—ADRA1A—Signaling by GPCR—EGFR—dilated cardiomyopathy	2.75e-05	0.000173	CbGpPWpGaD
Trazodone—CYP2D6—Metabolism—CD36—dilated cardiomyopathy	2.74e-05	0.000173	CbGpPWpGaD
Trazodone—ABCB1—Metabolism—AGT—dilated cardiomyopathy	2.62e-05	0.000165	CbGpPWpGaD
Trazodone—ADRA2A—Signaling by GPCR—EGFR—dilated cardiomyopathy	2.55e-05	0.000161	CbGpPWpGaD
Trazodone—CYP2D6—Metabolism—AGT—dilated cardiomyopathy	2.47e-05	0.000156	CbGpPWpGaD
Trazodone—HTR2A—Signaling Pathways—RAF1—dilated cardiomyopathy	2.42e-05	0.000153	CbGpPWpGaD
Trazodone—HRH1—Signaling Pathways—RAF1—dilated cardiomyopathy	2.41e-05	0.000152	CbGpPWpGaD
Trazodone—ADRA1A—Signaling Pathways—RAF1—dilated cardiomyopathy	2.37e-05	0.000149	CbGpPWpGaD
Trazodone—HTR2B—Signaling Pathways—EGFR—dilated cardiomyopathy	2.37e-05	0.000149	CbGpPWpGaD
Trazodone—ADRA2A—Signaling Pathways—RAF1—dilated cardiomyopathy	2.2e-05	0.000139	CbGpPWpGaD
Trazodone—HTR1A—Signaling Pathways—EGFR—dilated cardiomyopathy	1.92e-05	0.000121	CbGpPWpGaD
Trazodone—HTR2C—Signaling Pathways—EGFR—dilated cardiomyopathy	1.91e-05	0.00012	CbGpPWpGaD
Trazodone—CYP3A4—Metabolism—GPX1—dilated cardiomyopathy	1.84e-05	0.000116	CbGpPWpGaD
Trazodone—CYP3A4—Metabolism—CD36—dilated cardiomyopathy	1.79e-05	0.000113	CbGpPWpGaD
Trazodone—HTR2A—Signaling Pathways—EGFR—dilated cardiomyopathy	1.66e-05	0.000105	CbGpPWpGaD
Trazodone—HRH1—Signaling Pathways—EGFR—dilated cardiomyopathy	1.65e-05	0.000104	CbGpPWpGaD
Trazodone—ADRA1A—Signaling Pathways—EGFR—dilated cardiomyopathy	1.62e-05	0.000102	CbGpPWpGaD
Trazodone—CYP3A4—Metabolism—AGT—dilated cardiomyopathy	1.62e-05	0.000102	CbGpPWpGaD
Trazodone—ADRA2A—Signaling Pathways—EGFR—dilated cardiomyopathy	1.51e-05	9.52e-05	CbGpPWpGaD
